General Information of This Antigen
Antigen ID
TAR0MKNCY
Antigen Name
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
Gene Name
CEACAM5
Synonym
CEA; Carcinoembryonic antigen;Meconium antigen 100;CD_antigen=CD66e
Sequence
MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQ
HLFGYSWYKGERVDGNRQIIGYVIGTQQATPGPAYSGREIIYPNASLLIQNIIQNDTGFY
TLHVIKSDLVNEEATGQFRVYPELPKPSISSNNSKPVEDKDAVAFTCEPETQDATYLWWV
NNQSLPVSPRLQLSNGNRTLTLFNVTRNDTASYKCETQNPVSARRSDSVILNVLYGPDAP
TISPLNTSYRSGENLNLSCHAASNPPAQYSWFVNGTFQQSTQELFIPNITVNNSGSYTCQ
AHNSDTGLNRTTVTTITVYAEPPKPFITSNNSNPVEDEDAVALTCEPEIQNTTYLWWVNN
QSLPVSPRLQLSNDNRTLTLLSVTRNDVGPYECGIQNELSVDHSDPVILNVLYGPDDPTI
SPSYTYYRPGVNLSLSCHAASNPPAQYSWLIDGNIQQHTQELFISNITEKNSGLYTCQAN
NSASGHSRTTVKTITVSAELPKPSISSNNSKPVEDKDAVAFTCEPEAQNTTYLWWVNGQS
LPVSPRLQLSNGNRTLTLFNVTRNDARAYVCGIQNSVSANRSDPVTLDVLYGPDTPIISP
PDSSYLSGANLNLSCHSASNPSPQYSWRINGIPQQHTQVLFIAKITPNNNGTYACFVSNL
ATGRNNSIVKSITVSASGTSPGLSAGATVGIMIGVLVGVALI

    Click to Show/Hide
Family
CEA family
Function
Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression. Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6. Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells.

    Click to Show/Hide
Uniprot Entry
CEAM5_HUMAN
HGNC ID
HGNC:1817
KEGG ID
hsa:1048
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Actuximab
ADC Info ADC Name Payload Target Linker Ref
Actuximab-MMAE
Monomethyl auristatin E
Undisclosed
Mc-Val-Cit-PABC
[1]
Anti-CEACAM5 antibody
ADC Info ADC Name Payload Target Linker Ref
IBI3020
MMAE; TOP1 inhibitor
Microtubule (MT)+DNA topoisomerase 1 (TOP1)
A cleavable linker
[2]
ADC Info ADC Name Payload Target Linker Ref
B9-MMAE
Monomethyl auristatin E
Undisclosed
Mc-Val-Cit-PABC
[3]
ADC Info ADC Name Payload Target Linker Ref
BGA2588
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
[4]
BGA9962
ADC-C3 Payload
Undisclosed
Linker of ADC2-58
[4]
BGA8357
ADC-C3 Payload
Undisclosed
Linker of ADC2-51
[4]
BGA0084
BGA0084 Payload
Undisclosed
ADC-P1 BGB-C-269 Linker
[4]
BGA7413
ADC-C3 Payload
Undisclosed
BGA7413 Linker
[4]
BGA2490
ADC-C3 Payload
Undisclosed
BGA2490 Linker
[4]
BGA0179
ADC-C3 Payload
Undisclosed
BGA0179 Linker
[4]
CEA.5-G1fhL2
ADC Info ADC Name Payload Target Linker Ref
tWI857167B IC-12
undisclosed
Undisclosed
Undisclosed
[5]
ADC Info ADC Name Payload Target Linker Ref
Hu103-32-2-A (1)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
Hu103-32-2-A (2)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
ADC Info ADC Name Payload Target Linker Ref
Hu47-14-2-A
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
ADC Info ADC Name Payload Target Linker Ref
Hu63-13-2-A (1)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
Hu63-13-2-A (2)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
ADC Info ADC Name Payload Target Linker Ref
Hu67-14-2-A (1)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
Hu67-14-2-A (2)
RU2833323C1+Hu63-13-2-A+payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[6]
huIgG1 LALA
ADC Info ADC Name Payload Target Linker Ref
aCEA5-iduronide-exatecan
Exatecan
Undisclosed
MC-iduronide
[7]
aCEA5-K (Ac)-exatecan
Exatecan
Undisclosed
MC-K (Ac)VC
[7]
aCEA5-AAN-exatecan
Exatecan
Undisclosed
MC-AAN
[7]
aCEA5-iduronide-duocarmycin
Undisclosed
Undisclosed
MC-iduronide
[7]
Labetuzumab
ADC Info ADC Name Payload Target Linker Ref
Labetuzumab govitecan
SN-38
DNA topoisomerase 1 (TOP1)
CL2A
Lmab-CL2A-SN38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2E
[8]
DTPA-hMN-14-700DX
IRDye 700DX
Undisclosed
Undisclosed
[9]
Labetuzumab-PE40 conjugate
Pseudomonas exotoxin PE40
Eukaryotic elongation factor 2 kinase (EEF2K)
Undisclosed
[10]
Labetuzumab-CL2E-SN-38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2E
[11]
Labetuzumab-SN-38
Active metabolite of irinotecan SN38
DNA topoisomerase 1 (TOP1)
CL2A
[11]
JP7623413B2 ExampleADC47
Undisclosed
Undisclosed
Undisclosed
[12]
Precemtabart
ADC Info ADC Name Payload Target Linker Ref
Precemtabart tocentecan
Exatecan
DNA topoisomerase 1 (TOP1)
Mal-glucuronide-PABC
Tusamitamab
ADC Info ADC Name Payload Target Linker Ref
Tusamitamab ravtansine
DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
SGN-CEACAM5C
AMDCPT
DNA topoisomerase 1 (TOP1)
A cleavable linker
BGA7650
BGA7650 Payload
Undisclosed
BGA7650 Linker
[4]
undisclosed
ADC Info ADC Name Payload Target Linker Ref
CEA-targeted ISAC
Undisclosed
Undisclosed
Undisclosed
[13]
AU2020291014A1 IC-80
AU2020291014A1-Payload-69
Undisclosed
Aminobenzazepine-linker Formula II-69
[14]
WO2024110905A1 ADC1-2
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-2
[4]
WO2024110905A1 ADC1-4
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-4
[4]
WO2024110905A1 ADC1-11
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-11
[4]
WO2024110905A1 ADC2-2
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-2
[4]
WO2024110905A1 ADC2-4
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-4
[4]
WO2024110905A1 ADC2-6-2
ADC2-6-2 Payload
Undisclosed
Linker of ADC1-4
[4]
WO2024110905A1 ADC2-7-2
ADC2-6-2 Payload
Undisclosed
Linker of ADC2-7-2
[4]
WO2024110905A1 ADC2-9-1
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC2-9-1
[4]
WO2024110905A1 ADC2-9-2
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC2-9-1
[4]
WO2024110905A1 ADC2-10
Exatecan
Undisclosed
Linker of ADC2-10
[4]
WO2024110905A1 ADC2-11
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC1-11
[4]
WO2024110905A1 ADC2-22
ADC2-22 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC2-23
ADC2-23 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC2-24
ADC2-24 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC2-25
ADC2-25 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC2-26
ADC2-26 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC2-27
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-27
[4]
WO2024110905A1 ADC2-29
ADC2-29 Payload
Undisclosed
Linker of ADC2-29
[4]
WO2024110905A1 ADC2-30
ADC2-29 Payload
Undisclosed
Linker of ADC2-30
[4]
WO2024110905A1 ADC2-31
ADC2-29 Payload
Undisclosed
Linker of ADC2-31
[4]
WO2024110905A1 ADC2-32
ADC2-29 Payload
Undisclosed
Linker of ADC2-32
[4]
WO2024110905A1 ADC2-33
ADC2-29 Payload
Undisclosed
Linker of ADC2-33
[4]
WO2024110905A1 ADC2-34
ADC2-29 Payload
Undisclosed
Linker of ADC2-34
[4]
WO2024110905A1 ADC2-35
ADC2-29 Payload
Undisclosed
Linker of ADC2-35
[4]
WO2024110905A1 ADC2-36-1
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC2-36-1
[4]
WO2024110905A1 ADC2-36-2
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC2-36-1
[4]
WO2024110905A1 ADC2-37
ADC2-37 Payload
Undisclosed
Linker of ADC2-37
[4]
WO2024110905A1 ADC2-38
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-38
[4]
WO2024110905A1 ADC2-39
ADC2-29 Payload
Undisclosed
Linker of ADC2-39
[4]
WO2024110905A1 ADC2-40
ADC2-29 Payload
Undisclosed
Linker of ADC2-40
[4]
WO2024110905A1 ADC2-41
ADC2-29 Payload
Undisclosed
Linker of ADC2-41
[4]
WO2024110905A1 ADC2-42
ADC2-29 Payload
Undisclosed
Linker of ADC2-42
[4]
WO2024110905A1 ADC2-42-RO
ADC2-29 Payload
Undisclosed
Linker of ADC2-42
[4]
WO2024110905A1 ADC2-43
Monomethyl auristatin E
Microtubule (MT)
Linker of ADC2-43
[4]
WO2024110905A1 ADC2-44
ADC2-23 Payload
Undisclosed
Linker of ADC2-44
[4]
WO2024110905A1 ADC2-45
ADC2-45 Payload
Undisclosed
Linker of ADC2-44
[4]
WO2024110905A1 ADC2-46
ADC2-23 Payload
Undisclosed
Linker of ADC2-46
[4]
WO2024110905A1 ADC2-47
ADC2-45 Payload
Undisclosed
Linker of ADC2-47
[4]
WO2024110905A1 ADC2-48
ADC2-48 Payload
Undisclosed
Linker of ADC2-48
[4]
WO2024110905A1 ADC2-49
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-49
[4]
WO2024110905A1 ADC2-50
ADC2-29 Payload
Undisclosed
Linker of ADC2-50
[4]
WO2024110905A1 ADC2-51
ADC2-29 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC2-53
ADC2-29 Payload
Undisclosed
Linker of ADC2-53
[4]
WO2024110905A1 ADC2-54
ADC2-29 Payload
Undisclosed
Linker of ADC2-54
[4]
WO2024110905A1 ADC2-55
ADC2-45 Payload
Undisclosed
Linker of ADC2-30
[4]
WO2024110905A1 ADC2-56
ADC2-56 Payload
Undisclosed
Linker of ADC2-56
[4]
WO2024110905A1 ADC2-57
ADC2-29 Payload
Undisclosed
Linker of ADC2-57
[4]
WO2024110905A1 ADC2-58
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-58
[4]
WO2024110905A1 ADC2-59
ADC2-45 Payload
Undisclosed
Linker of ADC2-57
[4]
WO2024110905A1 ADC2-60
ADC2-29 Payload
Undisclosed
Linker of ADC2-60
[4]
WO2024110905A1 ADC2-61
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-61
[4]
WO2024110905A1 ADC2-62-1
Monomethyl auristatin E
Microtubule (MT)
ADC2-62-1 Linker
[4]
WO2024110905A1 ADC2-62-2
Monomethyl auristatin E
Microtubule (MT)
ADC2-62-1 Linker
[4]
WO2024110905A1 ADC2-63-1
Monomethyl auristatin E
Microtubule (MT)
ADC2-63-1 Linker
[4]
WO2024110905A1 ADC2-63-2
Monomethyl auristatin E
Microtubule (MT)
ADC2-63-1 Linker
[4]
WO2024110905A1 ADC2-64-1
Monomethyl auristatin E
Microtubule (MT)
ADC2-64-1 Linker
[4]
WO2024110905A1 ADC2-64-2
Monomethyl auristatin E
Microtubule (MT)
ADC2-64-1 Linker
[4]
WO2024110905A1 ADC2-65-1
Monomethyl auristatin E
Microtubule (MT)
ADC2-62-1 Linker
[4]
WO2024110905A1 ADC2-65-2
Monomethyl auristatin E
Microtubule (MT)
ADC2-64-1 Linker
[4]
WO2024110905A1 ADC3-1
ADC2-29 Payload
Undisclosed
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC3-2
ADC2-29 Payload
Undisclosed
Linker of ADC2-30
[4]
WO2024110905A1 ADC3-3
ADC2-29 Payload
Undisclosed
Linker of ADC2-32
[4]
WO2024110905A1 ADC3-4
ADC2-29 Payload
Undisclosed
Linker of ADC2-40
[4]
WO2024110905A1 ADC3-5
ADC2-45 Payload
Undisclosed
Linker of ADC2-44
[4]
WO2024110905A1 ADC3-6
ADC2-48 Payload
Undisclosed
Linker of ADC2-48
[4]
WO2024110905A1 ADC3-7
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-49
[4]
WO2024110905A1 ADC3-8
ADC2-29 Payload
Undisclosed
Linker of ADC2-50
[4]
WO2024110905A1 ADC3-9
ADC2-29 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC3-10
ADC2-45 Payload
Undisclosed
Linker of ADC2-30
[4]
WO2024110905A1 ADC3-11
ADC2-29 Payload
Undisclosed
Linker of ADC2-57
[4]
WO2024110905A1 ADC3-12
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-58
[4]
WO2024110905A1 ADC3-13
ADC2-45 Payload
Undisclosed
Linker of ADC2-57
[4]
WO2024110905A1 ADC3-14
ADC2-29 Payload
Undisclosed
Linker of ADC2-60
[4]
WO2024110905A1 ADC3-15
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC2-61
[4]
WO2024110905A1 ADC3-16
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC3-16
[4]
WO2024110905A1 ADC3-17
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Linker of ADC3-16
[4]
WO2024110905A1 ADC3-18
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Val-Ala
[4]
WO2024110905A1 ADC3-19
ADC3-19 Payload
Undisclosed
Linker of ADC3-19
[4]
WO2024110905A1 ADC3-20
ADC2-29 Payload
Undisclosed
Linker of ADC3-20
[4]
WO2024110905A1 ADC-C2
ADC2-29 Payload
Undisclosed
ADCC2-Linker
[4]
WO2024110905A1 ADC-C3
ADC-C3 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-C4
ADC-C4 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-C5
ADC-C4 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-P1 BGB-C-269
ADC2-29 Payload
Undisclosed
ADC-P1 BGB-C-269 Linker
[4]
WO2024110905A1 ADC-P2 BGB-C-276
ADC-C3 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-P3 BGB-C-290
ADC-P3 BGB-C-290 Payload
Undisclosed
ADC-P1 BGB-C-269 Linker
[4]
WO2024110905A1 ADC-1 BGB-C-81
DX-8951 derivative (DXd)
DNA topoisomerase 1 (TOP1)
Mc-Gly-Gly-Phe-Gly
[4]
WO2024110905A1 ADC-2 BGB-C-115
ADC2-29 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-3 BGB-C-245
ADC2-29 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-4 BGB-C-318
ADC2-29 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-5 BGB-C-277
ADC-5 BGB-C-277 Payload
Undisclosed
ADC-5 BGB-C-277 Linker
[4]
WO2024110905A1 ADC-6 BGB-C-306
ADC-6 BGB-C-306 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-7 BGB-C-329
ADC-7 BGB-C-329 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-8 BGB-C-323
ADC-8 BGB-C-323 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-9 BGB-C-331
ADC-9 BGB-C-331 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-10 BGB-C-325
ADC-10 BGB-C-325 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-11 BGB-C-307
ADC-11 BGB-C-307 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-12 BGB-C-287
ADC-12 BGB-C-287 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-13 BGB-C-288
ADC-13 BGB-C-288 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-14 BGB-C-317
ADC-14 BGB-C-317 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-15 BGB-C-292
ADC-15 BGB-C-292 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-16 BGB-C-348
ADC-16 BGB-C-348 Payload
Undisclosed
ADC-16 BGB-C-348 Linker
[4]
WO2024110905A1 ADC-17 BGB-C-319
ADC-17 BGB-C-319 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-18 BGB-C-343
ADC-18 BGB-C-343 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-19 BGB-C-302
ADC-19 BGB-C-302 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-20 BGB-C-320
ADC-20 BGB-C-320 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-21 BGB-C-330
ADC-21 BGB-C-330 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-22 BGB-C-346
ADC-22 BGB-C-346 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-23 BGB-C-358
ADC-23 BGB-C-358 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-24 BGB-C-373
ADC-24 BGB-C-373 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-25 BGB-C-421
ADC-25 BGB-C-421 Payload
Undisclosed
Linker of ADC2-51
[4]
WO2024110905A1 ADC-26 BGB-C-395
ADC-26 BGB-C-395 Payload
Undisclosed
ADC-26 BGB-C-395 Linker
[4]
References
Ref 1 A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors
Ref 2 Innovent Biologics announced that the world's first CEACAM5 dual-payload ADC (IBI3020) has completed the first patient administration in its Phase I clinical study
Ref 3 A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
Ref 4 Anti-CEA antibody drug conjugates and methods of use
Ref 5 Thienobenzodiazepine immunoconjugates and uses thereof
Ref 6 Conjugate of anti-CEA antibody and exatecan analog and pharmaceutical uses thereof
Ref 7 Generation and Characterization of Iduronidase-Cleavable ADCs
Ref 8 Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies. Mol Cancer Ther. 2012 Jan;11(1):224-34.
Ref 9 Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models. EJNMMI Res. 2019 Dec 11;9(1):108. doi: 10.1186/s13550-019-0580-z.
Ref 10 Introduction to basic information on ADC drug Labetuzumab-PE40 conjugate; 27 Oct 2020.
Ref 11 Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies. Mol Cancer Ther. 2012 Jan;11(1):224-34. doi: 10.1158/1535-7163.MCT-11-0632. Epub 2011 Oct 28.
Ref 12 Antibody-drug complexes containing hemiasterlin derivatives
Ref 13 A highly efficacious next-generation CEACAM5 (CEA)-targeted Boltbody™ ISAC for the treatment of colorectal, pancreatic and lung tumors
Ref 14 Aminobenzazepine compounds, immunoconjugates, and uses thereof